US Stocks
/
Altimmune, Inc. Share Price

Altimmune, Inc. Share Price

NASDAQ: ALT | Small Cap
$3.41
+$0.19 (5.74%) Last updated on 05 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Altimmune, Inc. Stock Performance

Open
$3.28
Prev. Close
$3.23
Circuit Range
N/A
Day Range
$3.25 - $3.42
Year Range
$2.56 - $6.42
Volume
1,54,294
Average Traded
$3.33

Altimmune, Inc. Share Price Today

As of 7 September 2026, Altimmune, Inc.'s share price is $3.41. The stock opened at $3.28, compared to its previous close of $3.23. During today's trading session, Altimmune, Inc.'s share price traded between $3.25 and $3.42, with an average price of $3.33. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.56. In terms of performance, Altimmune, Inc.'s share price has risen by 11.07% over the last six months and is down 9.55% on a year-on-year basis.

Altimmune, Inc. Share Price Chart

$3.25$3.42
L
Show Current Price
H

Altimmune, Inc. Stock Fundamentals & Key Indicators

Market Cap
$300.44M
PE Ratio (TTM)
-3.41
Dividend Yield
N/A
EPS (TTM)
$-1.00
Revenue (TTM)
$41000.00
Return On Equity (TTM)
-39.17%
Profit Margin
-214860.98%
Debt to Equity
0.07
Quarterly Earnings Growth YoY
16.77%

Altimmune, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$5000.00$5000.00$5000.00$5000.00$5000.00$5000.00
Net Profit-$24.39M-$24.64M-$22.84M-$19.57M-$22.15M-$19.01M
Net Profit Margin-487880.00%-492800.00%-456900.00%-391500.00%-442920.00%-380280.00%
Income ChangeN/A-1.01%7.28%14.31%-13.13%14.14%

Altimmune, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue$4.41M-$68000.00$426000.00$20000.00$41000.00
Net Profit-$97.09M-$84.71M-$88.45M-$95.06M-$88.09M
Net Profit Margin-2201.43%124577.94%-20762.21%-475295.00%-214860.98%
Income ChangeN/A12.75%-4.41%-7.48%7.33%

About Altimmune, Inc.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Altimmune, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$3.08
$3.42
+5.24%
Aug 2026
$2.90
$3.25
+13.86%
Jul 2026
$3.06
$2.85
-5.79%
Jun 2026
$3.03
$3.02
-0.82%
May 2026
$2.57
$3.05
+18.22%
Apr 2026
$3.15
$2.58
-15.96%
Mar 2026
$4.22
$3.07
-28.77%
Feb 2026
$5.55
$4.31
-23.17%
Jan 2026
$3.62
$5.61
+55.62%
Dec 2025
$5.08
$3.60
-31.46%
Nov 2025
$4.02
$5.26
+29.88%
Oct 2025
$3.83
$4.05
+7.43%

ALT Share Price FAQs

What is Altimmune, Inc. share price today?

chevron-up
Altimmune, Inc. share price today is $3.41 as on September 5, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Altimmune, Inc. stock?

chevron-up
The 52 week high of Altimmune, Inc. stock is $6.42, while the 52 week low is $2.56 as of 5 Sep '26.

What is ALT's market capitalisation today?

chevron-up
ALT market capitalisation is $300.44M as of September 7, 2026, at 5:23 am IST.

What is ALT's net income for the last quarter?

chevron-up
ALT's net income for the last quarter is -0.02B USD.

What is the 5 year returns of ALT?

chevron-up
The 5 year returns of ALT is -69.85% as on 5 Sep '26.

What is the high & low stock price of ALT today?

chevron-up
ALT stock price hit a high of $3.42 and low of $3.25 as of 5 Sep '26.

Can I buy ALT shares in India?

chevron-up
Yes. You can buy ALT in India by opening an international trading account.